Call Options

11 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2021

Feb 14, 2022

SELL
N/A
-298,500 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
N/A
186,900 Added 167.47%
298,500 $5.24 Million
Q2 2021

Aug 11, 2021

BUY
N/A
6,300 Added 5.98%
111,600 $1.08 Million
Q1 2021

May 17, 2021

SELL
N/A
-33,300 Reduced 24.03%
105,300 $1.13 Million
Q4 2020

Feb 16, 2021

BUY
N/A
61,100 Added 78.84%
138,600 $2.04 Million
Q3 2020

Nov 16, 2020

BUY
N/A
29,200 Added 60.46%
77,500 $1.1 Million
Q2 2020

Aug 14, 2020

BUY
N/A
8,100 Added 20.15%
48,300 $391,000
Q1 2020

May 15, 2020

BUY
N/A
40,200 New
40,200 $162,000
Q2 2018

Aug 14, 2018

SELL
N/A
-16,800 Closed
0 $0
Q1 2018

May 15, 2018

SELL
N/A
-17,800 Reduced 51.45%
16,800 $121,000
Q4 2017

Feb 14, 2018

BUY
N/A
34,600
34,600 $251,000

About Trillium Therapeutics Inc.


  • Ticker TRIL
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 104,995,000
  • Market Cap $1.94B
More about TRIL
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.